[Date Prev][Date Next][Thread Prev][Thread Next]
Author IndexDate IndexThread Index

Call for Applications: Research (travel) funding for work onhistory of pharmaceuticals, European Science Foundation

From:    "Carsten Timmermann" <carsten.timmermann@manchester.ac.uk>
Date:    Thu, April 17, 2008 10:57 am


The following call for applications issued by the new European Science
Foundation (ESF) Research Networking Programme DRUGS may be interesting
for postgrads or young postdoctoral researchers whose research involves
the history of pharmaceuticals, especially if it's on psychochemicals,
hormones or sera, drugs for cardiovascular diseases or antibiotics. The
ESF grant is meant to enable travel to any (or several) of the centres
involved in the programme (including Amsterdam, Berlin, Braunschweig,
Copenhagen, Granada, Lyon, Madrid, Manchester/Oxford, London, Oslo,
Paris, Strasbourg, Zurich), to work with members and explore relevant
local resources.

For details on the programme (and a downloadable version of the call for
applications), see the following website: http://drughistory.eu/

****************************************

*CALL FOR APPLICATIONS*

*Postgraduate/Postdoctoral Programme*

__Deadline: 15.05.2008__

Call for applications: Exchange/Travel grants (1600 EUR/month)

DRUGS is an European Science Foundation (ESF) Research Networking
Programme (RNP). For more information: http://drughistory.eu/

The ESF RNP "DRUGS" offers in 2008 four travel grants in the field of
modern drug history, notably oriented to the four following major drug
classes:
1.psychochemicals,
2.antibiotics,
3.hormones and sera,
4.cardiacs.

Each travel grant is awarded for a total of up to 24 weeks, spread over
2 to 4 visits. See the details below.

*Objectives*

The aim of the Postgraduate/Postdoctoral programme is to encourage young
researchers to engage in comparative international or transnational
research projects on the development of 20th century medicine with a
European perspective. This is to be accomplished, notably, by looking at
the production, distribution, prescription, and consumption of the four
major classes of therapeutic agents mentioned above. Rather than taking
20th century developments in the production and evaluation of drugs as
‘natural’ responses to a series of practical problems, the programme
encourages applicants to examine the evolution of industrial standards
and drug trials, alongside prescription and clinical practices. As such,
possible historical approaches may include inquiries into drug-related
accidents (adverse events) or proposed, but rejected, alternatives to
standard modern practice, etc. The programme aims to reveal the multiple
forces that have shaped our modern medical world through these
inquiries. Accordingly, proposals should extend beyond the history of
protagonists, research scientists and their clinical partners, in order
to orient contextualisation of the field with respect to interventions
of the state, industry, and other actors. Standardisation is, therein,
an analytical tool that outlines modern technological systems and
provides an interdisciplinary framework for understanding the
pharmaceuticals under consideration from the perspective of generalised
processes that lie behind most complex systems in modern societies. The
ultimate objective of the RNP is to obtain a richer view of the
interactions between pharmaceutical markets, industries, modern health
policies, and developments in medicine in order to open new perspectives
for the analysis of today’s health systems.

*The Network*

The network links relevant European research groups in the field of drug
histories. It promotes exchange between local working groups (see:
http://drughistory.eu/?Presentation:Research_network) with the purpose
of promoting collaborative research and comparative studies on shared
research topics. The central aim of the network is the development of a
wider European comparative perspective on a major topic in science and
technology of the 20th century. Using the theme of standardisation,
applied to objects and to practices, the network studies the various
ways of regulating drugs that were developed by European countries
during a critical period of pharmaceutical innovation and practice, that
is, from 1920 to 1990.

Framing the processes of standardisation is not restricted to
administrative pharmacopolitics. With "standardisation" the programme
denotes, in fact, a broad range of interventions along trajectories
which turned chemical or biological substances into drugs. These
transformations took place in laboratories, as well as, in clinical
practice (i.e., Clinical Gold Standards), alongside standardisation by
industrial production and bureaucratic regulation.

Furthermore, as standardisation is a theme that is common to a number of
disciplines, the proposed approach will open up interdisciplinary
discussion. Thus, the programme proposes an international networking
experience around a theme rich in historical terrain and contemporary
interest.


*Exchange Programme*

In 2008, a total of 4 travel grants are available.
The core of the RNP is the PhD/Postdoctoral training programme. This
will enable PhD and postdoctoral students to spend a term (a total of 24
weeks split into 2 to 4 exchange visits with local working groups) at
participating institutions of the network. The visits should be devoted
to specific research topics, around the four major drug classes listed
above. Students will choose a research topic, and contact the local
groups they wish to visit (see the website), according to the
methodological approaches they wish to consider and the topic they wish
to study.

The system of exchange has three aims. First, students will be able to
learn more about the specific approaches, methodologies, and cultures of
the different working groups. Secondly, the exchange will give them a
deeper understanding of the local and national specificities of research
organisation, local or national production, and state surveillance, and
especially of the national differences regarding archive conservation,
institutional arrangement of research facilities, and administration of
medicine and health care. Third, the programme promotes comparative
studies required for any meaningful transnational analysis.


*Application Process (Deadline: 15.05.2008)*

The grants will be distributed following an evaluation of the
applications responding to the call for application. Grantees will be
chosen based on the evaluation of their proposed projects. An evaluation
will also occur at the end of each travel term.

Applicants are asked to submit their application to the Programme
Coordinator, Christophe Masutti, by email:

christophe.masutti@charite.de

The application is to be a single document in PDF format.

Requested documents:
- A short description of the proposed project (apx. 1000 words) and the
objectives of the exchange (with a detailed planning)
- A curriculum vitae of two A4 pages
- A list of five most recent publications
- A letter of recommendation from someone familiar with the  
applicant’s work
- A letter of acceptance from the host at the receiving institution(s)
- Full address details of the prospective host(s)
- Proposed starting date
- Estimated travel costs


Travel grants requested cannot exceed 10.000 euro for the total of 24
weeks, based on an allowance of 400 euro per week, including travel
expenses.

For Exchange grants - upon receipt of the acceptance form, ESF makes an
advance payment (normally 80% of the allocated grant). The final payment
will be made upon the ESF’s receipt and approval of the scientific
report, signed host statement form(s) and original travel document(s).
In the case of cancellation or unreasonable delay (six months or more),
all advances must be returned to ESF. If the length of the stay is
shorter than the foreseen period, the grantee should reimburse the
surplus funds to ESF.
****************************************



-- 
Carsten Timmermann, PhD
Centre for the History of Science, Technology and Medicine
The University of Manchester, Simon Building, Room 2.36
Manchester M13 9PL, United Kingdom
Phone +44-(0)161-275 7950  Fax +44-(0)161-275 5699
Departmental Website: http://www.manchester.ac.uk/chstm
Project Website: http://www.cancer-history.org



••••••••••
History of Pharmacy Discussion Group
Moderator:  Greg Higby, American Institute of the History of Pharmacy
To subscribe or unsubscribe go to:
http://www.pharmweb.net/pwmirror/pwq/pharmwebqg.html
••••••••••




[Date Prev][Date Next][Thread Prev][Thread Next]
Author IndexDate IndexThread Index